Everest Pharma company information, Employees & Contact Information

Everest Medicines Invests $30.9M in I-Mab Contract Pharma

US$30.9 million strategic equity deal strengthens Everest’s oncology platform PharmaTimes

EVEREST: Dupilumab (Dupixent) Outperforms Omalizumab (Xolair) for CRSwNP, Asthma HCPLive

FDA approves IND application of Everest’s cancer vaccine Pharmaceutical Technology

Nefecon is Covered in China & the UK but not Korea: Officials & Academics Call for Change NAVLIN DAILY

GenScript spinoff Legend Biotech raises $424 million in IPO FirstWord Pharma

Fully occupied Bucks County warehouse trades for $37M The Business Journals

After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights Fierce Pharma

NSU launches Industrial Advisory Board for Pharmaceutical Sciences, partners with Beximco Pharma in pioneering MoU signing daily-sun.com

Breakdown Stocks: How to trade Orchid Pharma, Everest Industries and Jai Corp that hit a 52-week low? The Economic Times

Everest Medicines launches Nefecon in Mainland China The Pharma Letter

A2 Bio secures $80M to continue clinical testing of solid tumour CAR-Ts FirstWord Pharma

Everest debuts $130M mRNA vaccine plant with aim at Chinese market dominance Fierce Pharma

Everest’s Trodelvy receives approval for breast cancer in China Pharmaceutical Technology

Fierce Pharma Asia—Daiichi's €1B expansion; Astellas' $800M cell-therapy bet; Novartis India's strategic review Fierce Pharma

Fierce Pharma Asia—Biocon's biosimilar production faults; Fosun unit's PD-1 plan; Takeda-Finch IBD severance Fierce Pharma

Targeting a market Big Pharma's fleeing, Tetraphase wins FDA nod for antibiotic Xerava Fierce Pharma

Fierce Pharma Asia—Daiichi's ADC patent win; Roche's bet on Jemincare's PROTAC; AbbVie's CD47 retreat Fierce Pharma

Fierce Pharma Asia—Takeda's cell, gene therapy deals; BMS-BeiGene Abraxane brawl Fierce Pharma

Immunomedics finally wins its blockbuster FDA nod for Trodelvy in triple-negative breast cancer Fierce Pharma

FiercePharmaAsia—Hansoh-Hengrui billionaire family; Samsung executive's grilling; Aurobindo plant Fierce Pharma

Everest Organics launches 'Posaconazole' API Indian Pharma Post

Agilisium recognised as a leader in Everest Group life sciences digital services for mid-market enterprises PEAK matrix report Express Pharma

Manufacturing unregistered drugs: Young pharmacist association chief arrested, firm sealed The Express Tribune

TCS leads in Life Sciences operations services: Everest group Indian Pharma Post

14 more matches of Mini School Handball decided Bangladesh Sangbad Sangstha (BSS)

Drug agency bans sale and distribution of 16 medicines kathmandupost.com

DRAP ‘denies’ vital medicine to hepatitis C patients Dawn

Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio The Malaysian Reserve

For violating pollution norms, Everest Organics’ Telangana factory gets closure notice The News Minute

Pune: Dr Sanjay Chordiya honoured by IPA Free Press Journal

14 pharma companies allowed to manufacture hepatitis C oral drug Dawn

Meet Dhruv Malhotra, the man who bought Mankind Pharma’s Poonam Juneja’s Delhi property: Know about his journey & net worth financialexpress.com

BRAC University seminar raises awareness on prostate cancer Amader Barta

DRAP strikes back at PDLF chief to clarify its position The News International

Pharmaceuticals Companies sealed in Pakistan for manufacturing Fake Medicines Dispatch News Desk - DND